TGF-β and cancer
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The relationships between transforming growth factor-beta (TGF-beta) and cancer are varied and complex. The paradigm that is emerging from the experimental evidence accumulated over the past decade or so is that TGF-beta can play two different and opposite roles with respect to the process of malignant progression. During early stages of carcinogenesis, TGF-beta acts predominantly as a potent tumor suppressor and may mediate the actions of chemopreventive agents such as retinoids and nonsteroidal anti-estrogens. However, at some point during the development and progression of malignant neoplasms, bioactive TGF-betas make their appearance in the tumor microenvironment and the tumor cells escape from TGF-beta-dependent growth arrest. In many cases, this resistance to TGF-beta is the consequence of loss or mutational inactivation of the genes that encode signaling intermediates. These include the types I and II TGF-beta receptors, as well as receptor-associated and common-mediator Smads. The stage of tumor development or progression at which TGF-beta-resistant clones come to dominate the tumor cell population in different types of neoplasm remains to be defined. The phenotypic switch from TGF-beta-sensitivity to TGF-beta-resistance that occurs during carcinogenesis has several important implications for cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
Borkowski, T. A., Letterio, J. J., Farr, A. G., & Udey, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2417 · Cited by 474
Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dörries, R., Schlingensiepen, K.-H., & Brysch, W. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.6.0944 · Cited by 146
Research works printed but not linked: 272
- Roberts, 1993, Physiological actions and clinical applications of transforming growth factor-beta (TGF--beta), Growth Factors, 8, 1, 10.3109/08977199309029129 · DOI · Paper page
- Weinberg, 1997, The cat and mouse games that genes viruses and cells play, Cell, 88, 573, 10.1016/S0092-8674(00)81897-8 · DOI
- Rozenblum, 1997, Tumor-suppressive pathways in pancreatic carcinoma, Cancer Res., 57, 1731
- Sporn, 1989, Transforming growth factor-beta and suppression of carcinogenesis, Princess Takamatsu Symp., 20, 259
- Markowitz, 1996, Tumor suppressor activity of the TGF--beta pathway in human cancers, Cytokine Growth Factor Rev., 7, 93, 10.1016/1359-6101(96)00001-9 · DOI · Paper page
- Pierce Jr, 1995, Mammary tumor suppression by transforming growth factor beta 1 transgene expression, Proc. Natl. Acad. Sci. USA, 92, 4254, 10.1073/pnas.92.10.4254 · DOI · Paper page
- Glick, 1994, Targeted deletion of the TGF--beta 1 gene causes rapid progression to squamous cell carcinoma, Genes Dev., 8, 2429, 10.1101/gad.8.20.2429 · DOI · Paper page
- Tang, 1998, Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency, Nature M, 4, 802, 10.1038/nm0798-802 · DOI · Paper page
- Shida, 1998, Estrogen-induced tumorigenesis in the pituitary gland of TGF--beta (+/-) knockout mice, Biochim. Biophys. Acta, 1407, 79, 10.1016/S0925-4439(98)00024-6 · DOI
- Thorup, 1997, Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats relationship to growth factor expression, Carcinogenesis, 18, 465, 10.1093/carcin/18.3.465 · DOI
- Wu, 1992, TGF--beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector, J. Cell Biol., 116, 187, 10.1083/jcb.116.1.187 · DOI · Paper page
- Wu, 1993, Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties, Cell Growth Differ., 4, 115
- Wang, 1997, Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition, Proc. Natl. Acad. Sci. USA, 94, 2386, 10.1073/pnas.94.6.2386 · DOI · Paper page
- Jakubczak, 1997, Enhanced mammary tumorigenesis in transgenic mice expressing a dominant negative type II TGF-β receptor under the control of the MMTV-LTR, Proc. Am. Assoc. Cancer Res., 38, 580
- Pasche, 1998, Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract, Cancer Res., 58, 2727
- Chen, 1999, Structural alterations of transforming growth factor-β receptor genes in cervical carcinoma, Int. J. Cancer, 82, 43, 10.1002/(SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0 · doi:10.1002/(sici)1097-0215(19990702)82:1<43::aid-ijc9>3.0.co;2-0
- Zhu, 1998, Smad3 mutant mice develop metastatic colorectal cancer, Cell, 94, 703, 10.1016/S0092-8674(00)81730-4 · DOI · Paper page
- Takaku, 1998, Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes, Cell, 92, 645, 10.1016/S0092-8674(00)81132-0 · DOI · Paper page
- Sirard, 1998, The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo, Genes Dev., 12, 107, 10.1101/gad.12.1.107 · DOI · Paper page
- Reiss, 1997, Transfer of chromosome 18 into human head and neck squamous carcinoma cells Evidence for tumor suppression by Smad4/DPC4, Cell Growth Diff., 8, 407
- Grau, 1997, Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells, Cancer Res., 57, 3929
- Hunt, 1998, Overexpression of tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and agrowth inhibition in human carcinoma cells, Cancer Res., 58, 5656
- Zhou, 1998, Targeted deletion of smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells [In Process Citation], Proc. Natl. Acad. Sci. USA, 95, 2412, 10.1073/pnas.95.5.2412 · DOI · Paper page
- DeLarco, 1978, Growth factors from murine sarcoma virus-transformed cells, Proc. Natl. Acad. Sci. USA, 75, 4001, 10.1073/pnas.75.8.4001 · DOI · Paper page
- Corcione, 1993, Br. J. Haematol., 85, 684, 10.1111/j.1365-2141.1993.tb03209.x · doi:10.1111/j.1365-2141.1993.tb03209.x
- Cupp, 1993, Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS, Oncogene, 8, 2231
- Michelson, 1994, Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1, J. Virol., 68, 5730, 10.1128/jvi.68.9.5730-5737.1994 · DOI
- Cayrol, 1995, Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF--beta igh3) and TGF--beta 1, J. Virol., 69, 4206, 10.1128/jvi.69.7.4206-4212.1995 · DOI
- Schultz-Cherry, 1996, Influenza virus neuraminidase activates latent transforming growth factor beta, J. Virol., 70, 8624, 10.1128/jvi.70.12.8624-8629.1996 · DOI · Paper page
- Yoo, 1996, Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis, J. Clin. Invest., 97, 388, 10.1172/JCI118427 · DOI
- Dey, 1997, HPV 16 E6 oncoprotein stimulates the Transforming Growth Factor-beta-1 promoter In fibroblasts through a specific GC-rich sequence, Virology, 228, 190, 10.1006/viro.1996.8363 · DOI
- Creek, 1995, Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes, Adv. Exp. Med. Biol., 375, 117, 10.1007/978-1-4899-0949-7_11 · DOI
- Roberts, 1983, Transforming growth factors from neoplastic and nonneoplastic tissues, Fed. Proc., 42, 2621
- Nishimura, 1986, High level of beta-type transforming growth factor activity in human urine obtained from cancer patients Jpn J, Cancer Res., 77, 560
- Tsushima, 1996, High levels of transforming growth factor beta 1 in patients with colorectal cancer association with disease progression, Gastroenterology, 110, 375, 10.1053/gast.1996.v110.pm8566583 · DOI · Paper page
- Perry, 1997, Transforming growth factor beta as a clinical biomarker for prostate cancer, Urology 49, 151, 10.1016/S0090-4295(96)00426-8 · DOI
- Kong, 1995, Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor, Ann. Surg., 222, 155, 10.1097/00000658-199508000-00007 · DOI · Paper page
- Chopra, 1997, Serum levels of interleukins growth factors and angiogenin in patients with endometrial cancer, J. Cancer Res. Clin. Oncol., 123, 167
- Sminia, 1998, Plasma transforming growth factor beta levels in breast cancer patients, Oncol. Rep., 5, 485
- Maccallum, 1994, Expression of transforming growth factor beta mRNA isoforms in human breast cancer [see comments], Br. J. Cancer, 69, 1006, 10.1038/bjc.1994.197 · DOI
- Travers, 1988, Growth factor expression in normal benign and malignant breast tissue, Br. Med. J. (Clin. Res. Ed)., 296, 1621, 10.1136/bmj.296.6637.1621 · doi:10.1136/bmj.296.6637.1621
- Walker, 1992, Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast, Eur. J. Cancer, 28, 641, 10.1016/S0959-8049(05)80116-9 · DOI
- McCune, 1992, Localization of transforming growth factor-beta isotypes in lesions of the human breast [see comments], Hum. Pathol., 23, 13, 10.1016/0046-8177(92)90004-M · DOI
- Dalal, 1993, Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma, Am. J. Pathol., 143, 381
- Auvinen, 1995, Prognostic significance of TGF--beta 1 and TGF--beta 2 expressions in female breast cancer, Anticancer Res., 15, 2627
- De Jong, 1998, Expression of growth factors growth inhibiting factors and their receptors in invasive breast Cancer I An inventory in search of autocrine and paracrine loops, J. Pathol., 184, 44, 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H · DOI · Paper page
- Gorsch, 1992, Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer, Cancer Res., 52, 6949
- Hirayama, 1992, Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer, Hum. Pathol., 23, 681, 10.1016/0046-8177(92)90325-W · doi:10.1016/0046-8177(92)90325-w
- Mizoi, 1993, Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas qualitative difference between cancer cells and stromal cells, Cancer Res., 53, 183
- Kai, 1996, Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue, Jpn J. Cancer Res., 87, 296, 10.1111/j.1349-7006.1996.tb00220.x · doi:10.1111/j.1349-7006.1996.tb00220.x
- Morisaki, 1996, Immunosuppressive cytokines (IL-10 TGF--beta) genes expression in human gastric carcinoma tissues, J. Surg. Oncol., 63, 234, 10.1002/(SICI)1096-9098(199612)63:4<234::AID-JSO4>3.0.CO;2-D · doi:10.1002/(sici)1096-9098(199612)63:4<234::aid-jso4>3.0.co;2-d
- Naef, 1997, Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma, Int. J. Cancer, 71, 131, 10.1002/(SICI)1097-0215(19970410)71:2<131::AID-IJC1>3.0.CO;2-1 · doi:10.1002/(sici)1097-0215(19970410)71:2<131::aid-ijc1>3.0.co;2-1
- Mahara, 1994, Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue, Br. J. Cancer, 69, 777, 10.1038/bjc.1994.147 · DOI · Paper page
- Ura, 1991, Effects of transforming growth factor-beta released from gastric carcinoma cells on the contraction of collagen-matrix gels containing fibroblasts, Cancer Res., 51, 3550
- Yashiro, 1995, Establishment of two new scirrhous gastric cancer cell lines analysis of factors associated with disseminated metastasis, Br. J. Cancer, 72, 1200, 10.1038/bjc.1995.486 · doi:10.1038/bjc.1995.486
- Yashiro, 1996, Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts, Br. J. Cancer, 74, 1096, 10.1038/bjc.1996.496 · DOI
- Inoue, 1997, Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells, Jpn J. Cancer Res., 88, 152, 10.1111/j.1349-7006.1997.tb00360.x · DOI
- Cardillo, 1996, TGF--beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study, Arch. Anat. Cytol. Pathol., 44, 241
- Picon, 1998, A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1, Cancer Epidemiol. Biomarkers Prev., 7, 497
- Merz, 1994, Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate benign prostatic hyperplasia and prostatic cancer, World J. Urol., 12, 96, 10.1007/BF00184244 · DOI
- Truong, 1993, Association of transforming growth factor-beta 1 with prostate cancer an immunohistochemical study, Hum. Pathol., 24, 4, 10.1016/0046-8177(93)90055-L · DOI · Paper page
- Eastham, 1995, Transforming growth factor-beta 1 comparative immunohistochemical localization in human primary and metastatic prostate cancer, Lab. Invest., 73, 628
- Eklov, 1993, Lack of the latent transforming growth factor beta binding protein in malignant but not benign prostatic tissue, Cancer Res., 53, 3193
- Miyamoto, 1995, Expression of transforming growth factor-beta 1 in human bladder cancer, Cancer, 75, 2565, 10.1002/1097-0142(19950515)75:10<2565::AID-CNCR2820751025>3.0.CO;2-M · doi:10.1002/1097-0142(19950515)75:10<2565::aid-cncr2820751025>3.0.co;2-m
- Eder, 1997, Expression of transforming growth factors beta-1 beta 2 and beta 3 in human bladder carcinomas, Br. J. Cancer, 75, 1753, 10.1038/bjc.1997.299 · DOI
- Gold, 1994, Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium evidence for paracrine and autocrine action, Cancer Res., 54, 2347
- Comerci Jr, 1996, Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix, Cancer, 77, 1107, 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19960315)77:6<1107::aid-cncr16>3.0.co;2-5
- Kloen, 1997, Expression of transforming growth factor-beta (TGF--beta) isoforms in osteosarcomas TGF--beta3 is related to disease progression, Cancer, 80, 2230, 10.1002/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y · DOI · Paper page
- Bottinger, 1997, Expression of a dominant-negative mutant TGF--beta type II receptor in transgenic mice reveals essential roles for TGF--beta in regulation of growth and differentiation in the exocrine pancreas, Embo J., 16, 2621, 10.1093/emboj/16.10.2621 · DOI · Paper page
- Friedman, 1995, High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer, Cancer Epidemiol. Biomarkers Prev., 4, 549
- Doran, 1997, Oncogene and cytokine expression of human colorectal tumors responding to immunotherapy, J. Immunother., 20, 372, 10.1097/00002371-199709000-00006 · DOI
- Friess, 1993, Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival, Gastroenterology, 105, 1846, 10.1016/0016-5085(93)91084-U · DOI · Paper page
- Takanami, 1997, Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma results of an immunohistochemical study, J. Surg. Oncol., 64, 262, 10.1002/(SICI)1096-9098(199704)64:4<262::AID-JSO3>3.0.CO;2-7 · DOI
- Kim, 1998, Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients, Clin. Cancer Res., 4, 1625
- Murray, 1993, The prognostic significance of transforming growth factors in human breast cancer, Br. J. Cancer, 67, 1408, 10.1038/bjc.1993.261 · doi:10.1038/bjc.1993.261
- Welch, 1990, Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential, Proc. Natl. Acad. Sci. USA, 87, 7678, 10.1073/pnas.87.19.7678 · DOI · Paper page
- Arrick, 1992, Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1, J. Cell Biol., 118, 715, 10.1083/jcb.118.3.715 · DOI · Paper page
- Ueki, 1993, Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection, Jpn J. Cancer Res., 84, 589, 10.1111/j.1349-7006.1993.tb02017.x · DOI
- Oshima, 1996, TGF--beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis, Dev. Biol., 179, 297, 10.1006/dbio.1996.0259 · DOI · Paper page
- Mc Allister, 1994, Endoglin a TGF--beta binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1, Nat. Genet., 8, 345, 10.1038/ng1294-345 · DOI · Paper page
- McAllister, 1995, Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function, Hum. Mol. Genet., 4, 1983, 10.1093/hmg/4.10.1983 · DOI
- Johnson, 1996, Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat. Genet., 13, 189, 10.1038/ng0696-189 · DOI · Paper page
- Pepper, 1997, Transforming growth factor-beta vasculogenesis angiogenesis and vessel wall integrity, Cytokine Growth Factor Rev., 8, 21, 10.1016/S1359-6101(96)00048-2 · DOI · Paper page
- Ueki, 1992, Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis validity of neutralizing antibodies to block tumor growth, Biochim. Biophys. Acta, 1137, 189, 10.1016/0167-4889(92)90201-L · DOI
- De Jong, 1998, Expression of growth factors growth-inhibiting factors and their receptors in invasive breast Cancer II Correlations with proliferation and angiogenesis, J. Pathol., 184, 53, 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7 · DOI · Paper page
- Nakanishi, 1997, The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer, Int. J. Gynecol. Pathol., 16, 256, 10.1097/00004347-199707000-00011 · doi:10.1097/00004347-199707000-00011
- Choi, 1997, Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinoma, J. Korean Med. Sci., 12, 427, 10.3346/jkms.1997.12.5.427 · doi:10.3346/jkms.1997.12.5.427
- Merwin, 1990, Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis, J. Cell Physiol., 142, 117, 10.1002/jcp.1041420115 · DOI · Paper page
- Sankar, 1996, Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis, J. Clin. Invest., 97, 1436, 10.1172/JCI118565 · DOI · Paper page
- O'Mahony, 1998, Transforming growth factor-beta 1 inhibits generation of angiostatin by human pancreatic cancer cells, Surgery, 124, 388, 10.1016/S0039-6060(98)70145-X · DOI
- Benefield, 1996, Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas, Invasion Metastasis, 16, 291
- Patel, 1996, Changes in the immunohistochemical localisation of fibroblast growth factor-2 transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid, J. Endocrinol., 148, 485, 10.1677/joe.0.1480485 · doi:10.1677/joe.0.1480485
- Letterio, 1997, TGF--beta a critical modulator of immune cell function, Clin. Immunol. Immunopathol., 84, 244, 10.1006/clin.1997.4409 · DOI
- Arteaga, 1993, J. Clin. Invest., 92, 2569, 10.1172/JCI116871 · DOI · Paper page
- Fakhrai, 1996, Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy, Proc. Natl. Acad. Sci. USA, 93, 2909, 10.1073/pnas.93.7.2909 · DOI · Paper page
- Shull, 1992, Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease, Nature, 359, 693, 10.1038/359693a0 · DOI · Paper page
- Borkowski, 1997, A role for TGF-beta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGF-beta1 null mice, J. Clin. Invest., 100, 575, 10.1172/JCI119567 · DOI · Paper page
- Borkowski, 1997, Langerhans cells in the TGF- beta 1 null mouse, Adv. Exp. Med. Biol., 417, 307, 10.1007/978-1-4757-9966-8_50 · DOI
- Tada, 1991, Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state, J. Immunol., 146, 1077, 10.4049/jimmunol.146.3.1077 · DOI · Paper page
- Torre-Amione, 1990, A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance, Proc. Natl. Acad. Sci. USA, 87, 1486, 10.1073/pnas.87.4.1486 · DOI · Paper page
- Weiskirch, 1994, Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy, Cancer Immunol. Immunother., 38, 215, 10.1007/BF01533512 · doi:10.1007/bf01533512
- Jachimczak, 1996, Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides, Int. J. Cancer, 65, 332, 10.1002/(SICI)1097-0215(19960126)65:3<332::AID-IJC10>3.0.CO;2-C · DOI · Paper page
- Park, 1997, Expression of an antisense Transforming Growth Factor-Beta-1 transgene reduces tumorigenicity of EMT6 mammary tumor cells, Cancer Gene Therapy, 4, 42
- Tzai, 1998, Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer, Anticancer Res., 18, 1585
- Munger, 1997, Latent transforming growth factor-beta structural features and mechanisms of activation, Kidney Int., 51, 1376, 10.1038/ki.1997.188 · DOI · Paper page
- Miyazono, 1988, Latent high molecular weight complex of transforming growth factor-β from human platelets; a high molecular weight complex containing precursor sequences, J. Biol. Chem., 263, 6407, 10.1016/S0021-9258(18)68800-3 · DOI · Paper page
- Massagué, 1996, TGF--β signaling Receptors transducers and MAD proteins, Cell, 85, 947, 10.1016/S0092-8674(00)81296-9 · DOI · Paper page
- Valverius, 1989, Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells, Cancer Res., 49, 6269
- Arteaga, 1988, Transforming growth factor beta potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells, Cancer Res., 48, 3898
- Kalkhoven, 1995, The role of TGF--β production in growth inhibition of breast tumor cells by progestins, Int. J. Cancer, 61, 80, 10.1002/ijc.2910610114 · DOI
- Barcellos-Hoff, 1994, Transforming growth factor-beta activation in irradiated murine mammary gland, J. Clin. Invest., 93, 892, 10.1172/JCI117045 · DOI · Paper page
- Ehrhart, 1997, Latent transforming growth factor beta1 activation in situ quantitative and functional evidence after low-dose gamma-irradiation, Faseb J., 11, 991, 10.1096/fasebj.11.12.9337152 · DOI · Paper page
- Fowlis, 1992, Discordant localisation of TGF-β RNA and protein during chemical carcinogenesis in mouse skin, Cell Growth Differ., 3, 81
- Esherick, 1993, Transforming growth factorβ1 induction is associated with transforming growth factorβ2 and β3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia, Cancer Res., 53, 5507
- Jirtle, 1993, Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors, Cancer Res., 53, 3849
- Mansbach, 1996, Phenobarbital selectively promotes initiated cells with reduced TGF- beta receptor levels, Carcinogenesis, 17, 171, 10.1093/carcin/17.1.171 · doi:10.1093/carcin/17.1.171
- Crawford, 1998, Thrombospondin-1 is a major activator of TGF-β1 in vivo, Cell, 93, 1159, 10.1016/S0092-8674(00)81460-9 · DOI · Paper page
- Schultz-Cherry, 1993, Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism [published erratum appears in J. Cell Biol. (1993) Sep; 122 (5) following 1143], J. Cell Biol., 122, 923, 10.1083/jcb.122.4.923 · DOI · Paper page
- Schultz-Cherry, 1994, Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system, J. Biol. Chem., 269, 26775, 10.1016/S0021-9258(18)47086-X · DOI · Paper page
- Schultz-Cherry, 1994, The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta, J. Biol. Chem., 269, 26783, 10.1016/S0021-9258(18)47087-1 · DOI · Paper page
- Penttinen, 1988, Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability, Proc. Natl. Acad. Sci. USA, 85, 1105, 10.1073/pnas.85.4.1105 · DOI · Paper page
- Schultz-Cherry, 1995, Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1, J. Biol. Chem., 270, 7304, 10.1074/jbc.270.13.7304 · DOI · Paper page
- Guo, 1997, Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1, J. Pept. Res., 50, 210, 10.1111/j.1399-3011.1997.tb01187.x · DOI
- Guo, 1997, Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells, Cancer Res., 57, 1735
- Raychaudhury, 1994, Comparison of normal and tumorigenic endothelial cells differences in thrombospondin production and responses to transforming growth factor-beta, J. Cell Sci., 107, 39, 10.1242/jcs.107.1.39 · DOI
- Sheibani, 1995, Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis, Proc. Natl. Acad. Sci. USA, 92, 6788, 10.1073/pnas.92.15.6788 · DOI · Paper page
- Roberts, 1996, Regulation of tumor growth and metastasis by thrombospondin-1, Faseb J., 10, 1183, 10.1096/fasebj.10.10.8751720 · DOI · Paper page
- Hsu, 1996, Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1, Cancer Res., 56, 5684
- Fynan, 1993, Resistance to inhibition of cell growth by Transforming Growth Factor-β and its role in oncogenesis, Crit. Rev. Oncogenesis, 4, 493
- Rodeck, 1994, Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells, Cancer Res., 54, 575
- Hurteau, 1994, Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites, Cancer, 74, 93, 10.1002/1097-0142(19940701)74:1<93::AID-CNCR2820740117>3.0.CO;2-P · doi:10.1002/1097-0142(19940701)74:1<93::aid-cncr2820740117>3.0.co;2-p
- Havrilesky, 1995, Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta, Cancer Res., 55, 944
- Taetle, 1993, Effects of transforming growth factor beta 1 on growth and apoptosis of human acute myelogenous leukemia cells, Cancer Res., 53, 3386
- Haddow, 1991, Loss of growth control by TGF--beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation, Oncogene, 6, 1465
- Missero, 1991, Escape from transforming growth factor b control and oncogene cooperation in skin tumor development, Proc. Natl. Acad. Sci. USA, 88, 9613, 10.1073/pnas.88.21.9613 · DOI · Paper page
- Boukamp, 1995, Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53 rasH oncogene activation and additional chromosome loss, Oncogene, 11, 961
- Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF--beta) conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta, Oncogene, 6, 1471
- Hague, 1993, Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis, Cancer Metastasis Rev., 12, 227, 10.1007/BF00665955 · DOI
- DeGeest, 1994, Differential response of cervical intraepithelial and cervical carcinoma cell lines to Transforming Growth Factor-β1, Gyn. Oncol., 55, 376, 10.1006/gyno.1994.1310 · doi:10.1006/gyno.1994.1310
- Markowitz, 1994, A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene, J. Clin. Invest., 93, 1005, 10.1172/JCI117048 · DOI
- Kadin, 1994, Loss of receptors for transforming growth factor β in human T-cell malignancies, Proc. Natl. Acad. Sci. USA, 91, 6002, 10.1073/pnas.91.13.6002 · DOI · Paper page
- Capocasale, 1995, Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T-cells from Sézary patients, Proc. Natl. Acad. Sci. USA, 92, 5501, 10.1073/pnas.92.12.5501 · DOI
- Knaus, 1996, A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma, Mol. Cell Biol., 16, 3480, 10.1128/MCB.16.7.3480 · DOI · Paper page
- Reiss, 1997, Transforming growth factor-beta and cancer a love-hate relationship?, Oncol Res., 9, 447
- Massague, 1996, Serine/threonine kinase receptors mediators of transforming growth factor beta family signals, Cancer Surv., 27, 41
- Derynck, 1997, TGF--b receptor signaling, Biochim. Biophys. Acta, 1333, F105
- Saitoh, 1996, Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of Transforming Growth Factor-β, J. Biol. Chem., 271, 2769, 10.1074/jbc.271.5.2769 · DOI
- Kim, 1996, Genetic change in transforming growth factor beta (TGF--beta) receptor type I gene correlates with insensitivity to TGF--beta 1 in human prostate cancer cells, Cancer Res., 56, 44
- Kim, 1998, The conventional transforming growth factor-beta (TGF--beta) receptor type I is not required for TGF--beta 1 signaling in a human prostate cancer cell line LNCaP, Exp. Cell Res., 241, 151, 10.1006/excr.1998.4034 · DOI
- Goggins, 1998, Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas, Cancer Res., 58, 5329
- Chen, 1998, Transforming Growth Factor-β type I receptor kinase mutant associated with metastatic breast cancer, Cancer Res., 58, 4805
- Guo, 1997, Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF--beta1) type I and type II receptors in human prostate cancer, Int. J. Cancer, 71, 573, 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.0.CO;2-D · DOI · Paper page
- Baldwin, 1996, Attenuated ALK5 receptor expression in human pancreatic cancer correlation with resistance to growth inhibition, Int. J. Cancer, 67, 283, 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B · DOI
- Lu, 1997, Presence of two signaling TGF--beta receptors in human pancreatic cancer correlates with advanced tumor stage, Dig. Dis. Sci., 42, 2054, 10.1023/A:1018814416903 · DOI
- Baldwin, 1993, Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1, Growth Factors, 8, 23, 10.3109/08977199309029131 · DOI
- Kleeff, 1998, Up-regulation of transforming growth factor (TGF-)-beta receptors by TGF--beta1 in COLO-357 cells, J. Biol. Chem., 273, 7495, 10.1074/jbc.273.13.7495 · DOI
- Wagner, 1998, Transfection of the type I TGF--beta receptor restores TGF--beta responsiveness in pancreatic cancer, Int. J. Cancer, 78, 255, 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8 · DOI · Paper page
- Kimchi, 1988, Absence of TGF--beta receptors and growth inhibitory responses in retinoblastoma cells, Science, 240, 196, 10.1126/science.2895499 · DOI · Paper page
- Horie, 1998, Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells, J. Cell Physiol., 175, 305, 10.1002/(SICI)1097-4652(199806)175:3<305::AID-JCP8>3.0.CO;2-S · DOI
- Park, 1994, Genetic changes in the transforming growth factor beta (TGF--beta) type II receptor gene in human gastric cancer cells correlation with sensitivity to growth inhibition by TGF--beta, Proc. Natl. Acad. Sci. USA, 91, 8772, 10.1073/pnas.91.19.8772 · DOI · Paper page
- Sun, 1994, Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells, J. Biol. Chem., 269, 26449, 10.1016/S0021-9258(18)47215-8 · DOI · Paper page
- Kalkhoven, 1995, Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines, Cell Growth Differ., 6, 1151
- De Jonge, 1997, Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells, Oncol. Res, 9, 89
- Markowitz, 1995, Inactivation of the type II TGF--beta receptor in colon cancer cells with microsatellite instability [see comments], Science, 268, 1336, 10.1126/science.7761852 · DOI · Paper page
- Myeroff, 1995, A transforming growth factor β type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability, Cancer Res., 55, 5545
- Parsons, 1995, Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer, Cancer Res., 55, 5548
- Wang, 1995, Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells, J. Biol. Chem., 270, 22044, 10.1074/jbc.270.37.22044 · DOI · Paper page
- Lu, 1995, Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer, Biochem. Biophys. Res. Commun., 216, 452, 10.1006/bbrc.1995.2644 · doi:10.1006/bbrc.1995.2644
- Abe, 1996, The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability, Eur. J. Surg. Oncol., 22, 474, 10.1016/S0748-7983(96)92824-3 · DOI
- Akiyama, 1996, Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability, Cancer, 78, 2478, 10.1002/(SICI)1097-0142(19961215)78:12<2478::AID-CNCR5>3.0.CO;2-G · doi:10.1002/(sici)1097-0142(19961215)78:12<2478::aid-cncr5>3.0.co;2-g
- Ohue, 1996, Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer, Int. J. Cancer, 68, 203, 10.1002/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B · DOI · Paper page
- Lu, 1996, Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers, Cancer Res., 56, 4595
- Konishi, 1996, Molecular nature of colon tumors in hereditary nonpolyposis colon cancer familial polyposis and sporadic colon cancer [see comments], Gastroenterology, 111, 307, 10.1053/gast.1996.v111.pm8690195 · DOI · Paper page
- Renault, 1996, Microsatellite instability and mutations of p53 and TGF--beta RII genes in gastric cance, r, Human Gen., 98, 601, 10.1007/s004390050267 · DOI
- Samowitz, 1997, Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas, Am. J. Pathol., 151, 33
- Chang, 1997, Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells, Cancer Res., 57, 2856
- Mackay, 1998, 3rd Transfection of the type II TGF--beta receptor into colon cancer cells increases receptor expression inhibits cell growth and reduces the malignant phenotype, Ann. Surg., 227, 781, 10.1097/00000658-199806000-00001 · doi:10.1097/00000658-199806000-00001
- Izumoto, 1997, Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas, Cancer Lett., 112, 251, 10.1016/S0304-3835(96)04583-1 · DOI
- Takenoshita, 1997, Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers, Oncogene, 14, 1255, 10.1038/sj.onc.1200938 · DOI
- Vincent, 1997, Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta, Oncogene, 15, 117, 10.1038/sj.onc.1201166 · doi:10.1038/sj.onc.1201166
- Shitara, 1998, Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas, Int. J. Oncol., 12, 1061
- Rashid, 1997, Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine, Gastroenterology, 113, 127, 10.1016/S0016-5085(97)70087-8 · DOI
- Garrigue-Antar, 1995, Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells, Cancer Res., 55, 3982
- Wang, 1997, Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck, Carcinogenesis, 18, 2285, 10.1093/carcin/18.11.2285 · DOI
- Orimo, 1998, A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability, Mutat. Res., 382, 115
- Lynch, 1998, Mutational analysis of the Transforming Growth Factor β receptor type II gene in human ovarian cancer, Cancer Res., 58, 4227
- Grady, 1999, Mutational inactivation of transforming growth factor-b receptor type II in microsatellite stable colon cancers, Cancer Res., 59, 320
- De, 1998, Functional characterization of transforming growth factor beta type II receptor mutants in human cancer, Cancer Res., 58, 1986
- Knudson, 1985, Heredity cancer oncogenesand antioncogenes, Cancer Res., 45, 1437
- Akiyama, 1997, Transforming Growth Factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer, Gastroenterology, 112, 33, 10.1016/S0016-5085(97)70216-6 · DOI
- Grady, 1998, Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas, Cancer Res., 58, 3101
- Gollerkeri, 1999, Allelic loss of transforming growth factor-β receptor genes in primary breast cancer detected by fluorescence in-situ hybridization lab. invest., Proc. Am. Assoc. Cancer Res., 40, 134
- Lin, 1992, Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase, Cell, 68, 775, 10.1016/0092-8674(92)90152-3 · DOI · Paper page
- Garrigue-Antar, 1996, Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer, Lab. Invest., 75, 263
- Munoz-Antonia, 1996, A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression, Cancer Res., 56, 4831
- Inagaki, 1993, Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA, Proc. Natl. Acad. Sci. USA, 90, 5359, 10.1073/pnas.90.11.5359 · DOI · Paper page
- Guo, 1998, Overexpression of transforming growth factor (TGF-) beta1 type II receptor restores TGF--beta1 sensitivity and signaling in human prostate cancer cells, Cell Growth Differ., 9, 185
- Derynck, 1996, Intracellular signalling: The Mad way to do it, Curr. Biol., 6, 1226, 10.1016/S0960-9822(96)00702-6 · DOI · Paper page
- Macias-Silva, 1996, MADR2 Is a substrate of the TGF--β receptor and its phosphorylation is required for nuclear accumulation and sigaling, Cell, 87, 1215, 10.1016/S0092-8674(00)81817-6 · DOI · Paper page
- Hayashi, 1997, The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7 · DOI · Paper page
200 of 272 shown
Cited by
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
Transforming growth factor-β in cancer and metastasis
Jakowlew, S. B. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9006-2 · Cited by 517
Metadata
- Authors
- Reiss, M.
- Venue
- Microbes and Infection
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 1
- Issue
- 15
- Pages
- 1327-1347
- ISSN
- 1286-4579 (ISSN-L)
- OpenAlex
- W2086286077
- Cited by
- 118
- References
- 6
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 460 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TGF-β and cancer. https://app.cochat.ai/papers/10.1016/s1286-4579(99)00251-8
- The paper
- Reiss, M. (1999). TGF-β and cancer. Microbes and Infection. https://doi.org/10.1016/s1286-4579(99)00251-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.